In this video, Marc Raab, MD, German Cancer Research Center, Heidelberg, Germany, discusses targeted therapies for the treatment of patients with relapsed/refractory (R/R) multiple myeloma (MM), highlighting some of the novel approaches and drug classes being investigated. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть